… HPV vaccine. In an effectiveness study covering the entire Swedish population, HPV vaccine
effectiveness against genital warts … <14 years) and vaccine effectiveness decreased with …

… the impact of the HPV vaccine program on in-patient treatment of genital warts in Australia. …
for genital warts in the youngest (15–24 year old) women after the HPV vaccination program …

… We did not observe declines in the incidences of genital … younger women was due to the
HPV vaccination program. … of the HPV vaccine and implementation of the vaccination program. …

… In 2012, the program was supplemented with a catch-up program for women aged up to 27
… of the Danish vaccination program on the nationwide incidence of genital warts (GWs), after …

… evidence that the quadrivalent HPV vaccination program has led to a decreased management
rate of genital warts in general practice among those women of vaccine-eligible age. This …

… quadrivalent HPV vaccine were effective against genital warts in our population. Moreover,
with low vaccine coverage the incidence of genital warts decreased only in the vaccinated. …

… genital warts hospitalisations according to socioeconomic and geographic factors, both
in females vaccinated at school and in the community. The indirect impact on genital warts …

… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged 14–23 years and to estimate the incidence of GW in the whole population aged from …

Assess Ontario's school-based human papillomavirus (HPV) vaccination program on reducing
rates of cervical dysplasia, colposcopy services and treatment for genital warts, cervical …

… Approximately 70% of cervical cancer is caused by infection with HPV types 16 and 18 and
∼90% of genital warts are caused by HPV types 6 and 11. The quadrivalent HPV vaccine …